KURT A GUSTAFSON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KURT A GUSTAFSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KURT A GUSTAFSON. KURT A GUSTAFSON is EVP & Chief Financial Officer in SPECTRUM PHARMACEUTICALS INC ($SPPI) and Vice President and CFO in HALOZYME THERAPEUTICS INC ($GYHT) and VP, Chief Financial Officer in HALOZYME THERAPEUTICS INC ($GYHT) and in Xencor Inc ($XNCR) and Director in Xencor Inc ($XNCR) and in ChromaDex Corp. ($CDYE3).
Latest Insider Trading Transactions of KURT A GUSTAFSON
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CDXC, GYHT, SPPI, XNCR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2021 | XNCR | Xencor Inc | GUSTAFSON KURT A | Option Exercise | A | 36.01 | 9,728 | 350,305 | 9,728 | ||
| Mar 17 2021 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 3.69 | 16,318 | 60,213 | 400,451 | 416.8 K to 400.5 K (-3.92 %) |
| Mar 17 2021 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 3.63 | 20,365 | 73,823 | 416,769 | 437.1 K to 416.8 K (-4.66 %) |
| Feb 23 2021 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Option Exercise | A | 3.56 | 340,618 | 1,212,600 | 340,618 | |
| Feb 23 2021 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Option Exercise | A | 3.56 | 144,944 | 516,001 | 144,944 | |
| Feb 23 2021 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 3.73 | 4,000 | 14,920 | 437,134 | 441.1 K to 437.1 K (-0.91 %) |
| Feb 23 2021 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 3.64 | 4,672 | 16,992 | 441,134 | 445.8 K to 441.1 K (-1.05 %) |
| Feb 23 2021 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Grant | A | 0.00 | 119,579 | 0 | 445,806 | 326.2 K to 445.8 K (+36.66 %) |
| Jan 20 2021 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 4.31 | 1,944 | 8,379 | 330,608 | 332.6 K to 330.6 K (-0.58 %) |
| Jan 20 2021 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 3.81 | 2,582 | 9,832 | 332,552 | 335.1 K to 332.6 K (-0.77 %) |
| Dec 16 2020 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 5.00 | 25,696 | 128,480 | 335,134 | 360.8 K to 335.1 K (-7.12 %) |
| Jun 29 2020 | XNCR | Xencor Inc | GUSTAFSON KURT A | Director | Option Exercise | A | 33.42 | 13,953 | 466,309 | 13,953 | |
| Jun 22 2020 | CDXC | ChromaDex Corp. | GUSTAFSON KURT A | Option Exercise | A | 4.67 | 20,000 | 93,400 | 20,000 | ||
| Jun 22 2020 | CDXC | ChromaDex Corp. | GUSTAFSON KURT A | Option Exercise | A | 4.67 | 20,000 | 93,400 | 20,000 | ||
| Apr 02 2020 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 2.23 | 3,135 | 6,991 | 360,830 | 364 K to 360.8 K (-0.86 %) |
| Apr 02 2020 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 2.31 | 4,326 | 9,989 | 363,965 | 368.3 K to 364 K (-1.17 %) |
| Mar 13 2020 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Option Exercise | A | 2.13 | 225,000 | 479,250 | 225,000 | |
| Mar 13 2020 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Option Exercise | A | 2.13 | 260,000 | 553,800 | 260,000 | |
| Mar 13 2020 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Grant | A | 0.00 | 163,180 | 0 | 368,291 | 205.1 K to 368.3 K (+79.56 %) |
| Feb 21 2020 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 2.85 | 3,333 | 9,499 | 205,111 | 208.4 K to 205.1 K (-1.60 %) |
| Feb 21 2020 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 2.77 | 4,733 | 13,115 | 208,444 | 213.2 K to 208.4 K (-2.22 %) |
| Jan 17 2020 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 3.33 | 1,621 | 5,398 | 231,955 | 233.6 K to 232 K (-0.69 %) |
| Jan 17 2020 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 3.37 | 2,522 | 8,492 | 233,576 | 236.1 K to 233.6 K (-1.07 %) |
| Jun 27 2019 | XNCR | Xencor Inc | GUSTAFSON KURT A | Director | Option Exercise | A | 39.08 | 12,731 | 497,527 | 12,731 | |
| Jun 24 2019 | CDYE3 | ChromaDex Corp. | GUSTAFSON KURT A | Option Exercise | A | 3.80 | 20,000 | 76,000 | 20,000 | ||
| Apr 01 2019 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 10.73 | 3,000 | 32,190 | 236,098 | 239.1 K to 236.1 K (-1.25 %) |
| Apr 01 2019 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 10.81 | 1,642 | 17,750 | 239,098 | 240.7 K to 239.1 K (-0.68 %) |
| Apr 01 2019 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 10.65 | 5,974 | 63,623 | 240,740 | 246.7 K to 240.7 K (-2.42 %) |
| Mar 27 2019 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 9.90 | 926 | 9,167 | 246,714 | 247.6 K to 246.7 K (-0.37 %) |
| Mar 25 2019 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 9.46 | 3,797 | 35,931 | 247,640 | 251.4 K to 247.6 K (-1.51 %) |
| Feb 20 2019 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Option Exercise | A | 11.71 | 90,000 | 1,053,900 | 90,000 | |
| Feb 20 2019 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Grant | A | 0.00 | 40,000 | 0 | 256,896 | 216.9 K to 256.9 K (+18.44 %) |
| Jan 18 2019 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 10.44 | 3,207 | 33,471 | 216,896 | 220.1 K to 216.9 K (-1.46 %) |
| Jan 11 2019 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 10.87 | 33,692 | 366,333 | 220,103 | 253.8 K to 220.1 K (-13.28 %) |
| Jan 11 2019 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Grant | A | 0.00 | 100,326 | 0 | 253,795 | 153.5 K to 253.8 K (+65.37 %) |
| Jun 27 2018 | XNCR | Xencor Inc | GUSTAFSON KURT A | Director | Option Exercise | A | 38.93 | 7,500 | 291,975 | 7,500 | |
| Jun 26 2018 | CDYE3 | ChromaDex Corp. | GUSTAFSON KURT A | Option Exercise | A | 3.83 | 20,000 | 76,600 | 20,000 | ||
| Jun 26 2018 | CDYE3 | ChromaDex Corp. | GUSTAFSON KURT A | Option Exercise | A | 3.83 | 20,000 | 76,600 | 20,000 | ||
| Mar 28 2018 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 16.35 | 4,350 | 71,123 | 187,193 | 191.5 K to 187.2 K (-2.27 %) |
| Mar 27 2018 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 17.38 | 1,300 | 22,594 | 191,543 | 192.8 K to 191.5 K (-0.67 %) |
| Mar 23 2018 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 18.13 | 2,640 | 47,868 | 192,843 | 195.5 K to 192.8 K (-1.35 %) |
| Jan 19 2018 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Option Exercise | A | 19.42 | 87,500 | 1,699,250 | 87,500 | |
| Jan 19 2018 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Grant | A | 0.00 | 19,445 | 0 | 195,483 | 176 K to 195.5 K (+11.05 %) |
| Jul 05 2017 | CDYE3 | ChromaDex Corp. | GUSTAFSON KURT A | Option Exercise | A | 3.59 | 20,000 | 71,800 | 20,000 | ||
| Jun 26 2017 | XNCR | Xencor Inc | GUSTAFSON KURT A | Director | Option Exercise | A | 22.20 | 7,500 | 166,500 | 7,500 | |
| Jun 05 2017 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Payment of Exercise | F | 5.96 | 9,395 | 55,994 | 171,393 | 180.8 K to 171.4 K (-5.20 %) |
| Mar 30 2017 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Option Exercise | A | 6.69 | 116,959 | 782,456 | 116,959 | |
| Mar 30 2017 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Payment of Exercise | F | 6.69 | 4,713 | 31,530 | 180,788 | 185.5 K to 180.8 K (-2.54 %) |
| Mar 30 2017 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Grant | A | 0.00 | 50,163 | 0 | 185,501 | 135.3 K to 185.5 K (+37.06 %) |
| Mar 28 2017 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Payment of Exercise | F | 6.61 | 1,410 | 9,320 | 135,338 | 136.7 K to 135.3 K (-1.03 %) |
| Mar 24 2017 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Payment of Exercise | F | 6.42 | 2,819 | 18,098 | 136,748 | 139.6 K to 136.7 K (-2.02 %) |
| Feb 22 2017 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Payment of Exercise | F | 5.91 | 2,471 | 14,604 | 139,567 | 142 K to 139.6 K (-1.74 %) |
| Nov 16 2016 | CDYE3 | ChromaDex Corp. | GUSTAFSON KURT A | Option Exercise | A | 2.88 | 40,000 | 115,200 | 40,000 | ||
| Jul 11 2016 | XNCR | Xencor Inc | GUSTAFSON KURT A | Director | Option Exercise | A | 14.83 | 7,500 | 111,225 | 7,500 | |
| Jun 03 2016 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Payment of Exercise | F | 7.52 | 10,040 | 75,501 | 144,122 | 154.2 K to 144.1 K (-6.51 %) |
| Mar 25 2016 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Payment of Exercise | F | 5.96 | 1,525 | 9,089 | 144,495 | 146 K to 144.5 K (-1.04 %) |
| Mar 24 2016 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Payment of Exercise | F | 6.08 | 3,010 | 18,301 | 146,020 | 149 K to 146 K (-2.02 %) |
| Mar 24 2016 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Grant | A | 0.00 | 30,000 | 0 | 149,030 | 119 K to 149 K (+25.20 %) |
| Feb 22 2016 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Payment of Exercise | F | 4.55 | 2,669 | 12,144 | 119,030 | 121.7 K to 119 K (-2.19 %) |
| Dec 18 2015 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Option Exercise | A | 5.86 | 300,000 | 1,758,000 | 300,000 | |
| Jun 11 2015 | XNCR | Xencor Inc | GUSTAFSON KURT A | Director | Option Exercise | A | 20.00 | 7,500 | 150,000 | 7,500 | |
| Jun 05 2015 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Payment of Exercise | F | 6.19 | 10,067 | 62,315 | 121,699 | 131.8 K to 121.7 K (-7.64 %) |
| Feb 06 2013 | GYHT | HALOZYME THERAPEUT ... | GUSTAFSON KURT A | Vice President and ... | Option Exercise | A | 0.00 | 37,200 | 0 | 37,200 | |
| Feb 06 2013 | GYHT | HALOZYME THERAPEUT ... | GUSTAFSON KURT A | Vice President and ... | Option Exercise | A | 6.55 | 62,000 | 406,100 | 62,000 | |
| Feb 05 2013 | GYHT | HALOZYME THERAPEUT ... | GUSTAFSON KURT A | Vice President and ... | Buy | M | 0.00 | 3,958 | 0 | 35,667 | 31.7 K to 35.7 K (+12.48 %) |
| Feb 05 2013 | GYHT | HALOZYME THERAPEUT ... | GUSTAFSON KURT A | Vice President and ... | Buy | M | 0.00 | 8,509 | 0 | 31,709 | 23.2 K to 31.7 K (+36.68 %) |
| May 17 2012 | GYHT | HALOZYME THERAPEUT ... | GUSTAFSON KURT A | Vice President and ... | Buy | M | 0.00 | 15,200 | 0 | 23,200 | 8 K to 23.2 K (+190.00 %) |
| Feb 06 2012 | GYHT | HALOZYME THERAPEUT ... | GUSTAFSON KURT A | VP, Chief Financial ... | Option Exercise | A | 0.00 | 74,271 | 0 | 74,271 | |
| Feb 06 2012 | GYHT | HALOZYME THERAPEUT ... | GUSTAFSON KURT A | VP, Chief Financial ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 06 2012 | GYHT | HALOZYME THERAPEUT ... | GUSTAFSON KURT A | VP, Chief Financial ... | Option Exercise | A | 11.29 | 50,000 | 564,500 | 50,000 | |
| Aug 10 2011 | GYHT | HALOZYME THERAPEUT ... | GUSTAFSON KURT A | Vice President and ... | Buy | P | 5.88 | 8,000 | 47,010 | 8,000 | 0 to 8 K |
| May 11 2011 | GYHT | HALOZYME THERAPEUT ... | GUSTAFSON KURT A | Vice President and ... | Option Exercise | A | 0.00 | 24,000 | 0 | 24,000 | |
| Feb 04 2011 | GYHT | HALOZYME THERAPEUT ... | GUSTAFSON KURT A | Vice President and ... | Option Exercise | A | 7.14 | 40,000 | 285,600 | 40,000 | |
| Feb 08 2010 | GYHT | HALOZYME THERAPEUT ... | GUSTAFSON KURT A | Vice President and ... | Option Exercise | A | 5.55 | 25,312 | 140,482 | 25,312 | |
| Feb 08 2010 | GYHT | HALOZYME THERAPEUT ... | GUSTAFSON KURT A | Vice President and ... | Option Exercise | A | 5.55 | 1,288 | 7,148 | 1,288 |
Page: 1